Skip to main content
. 2006 Jun 19;148(7):938–946. doi: 10.1038/sj.bjp.0706804

Figure 5.

Figure 5

Effect of the sensory neuropeptide antagonists Noci1–13 (10−9 mol: NOP receptor), [D-Arg]-SP (10−12 mol: NK1 receptor), CGRP8–37 (10−9 mol: CGRP receptor) and VIP6–28 (10−9 mol: VPAC receptor antagonist) on acutely inflamed knee joint basal blood flow. *P<0.05 two-tailed paired Student's t-test, n=7–10. NS: not significantly different. Data are shown as means±s.e.m.